Descovy and Social Security Disability Benefits
TELL US WHAT HAPPENED SO WE CAN HELP. FREE CONSULTATION
Contact Us About Your Case
FREE Consultation Today.
Descovy and Social Security Disability Benefits
Descovy is a prescription medication that contains two antiretroviral drugs:
- emtricitabine, or FTC
- tenofovir alafenamide, or TAF
Most often, Descovy is used as part of combination treatment for HIV-1 infection. It is also FDA-approved for HIV pre-exposure prophylaxis, or PrEP, in certain people who do not have HIV.
An important distinction for disability claims is that Descovy is not a complete HIV treatment regimen by itself. Current NIH guidelines identify Descovy as a two-drug NRTI fixed-dose combination that must be used with other antiretroviral medications when treating HIV.
Taking Descovy does not automatically qualify someone for Social Security Disability benefits.
Many people taking Descovy have well-controlled HIV and work without significant limitations. Others continue to experience:
- severe fatigue
- peripheral neuropathy
- cognitive problems
- recurrent infections
- chronic diarrhea
- headaches
- kidney disease
- liver problems
- residual complications from HIV
- treatment-related side effects
For Social Security, the key issue is whether HIV, related medical conditions, and treatment effects prevent sustained full-time competitive employment.
What Is Descovy?
Descovy combines:
- emtricitabine 200 mg
- tenofovir alafenamide 25 mg
in the standard adult tablet.
For HIV treatment, Descovy is taken once daily with or without food and must be combined with other appropriate antiretroviral medication. Current FDA labeling also provides lower-strength pediatric dosing in certain weight ranges.
Descovy differs from medications such as Biktarvy because Descovy contains only the NRTI “backbone” of an HIV regimen rather than all of the medications necessary for a complete regimen.
That distinction matters when reviewing medical records.
Can Taking Descovy Qualify You for Social Security Disability?
Not by itself.
A Descovy prescription documents HIV treatment in someone with HIV, but Social Security evaluates the underlying medical condition and its functional impact.
A stronger disability claim may exist when HIV or related conditions continue to cause:
- severe fatigue
- recurrent illness
- neuropathy
- cognitive impairment
- chronic gastrointestinal symptoms
- weakness
- kidney problems
- liver disease
- excessive medical appointments
- excessive absences
- inability to complete full shifts
The strongest claims connect those symptoms to actual workplace limitations.
Descovy and HIV Disability Claims
Adult HIV infection is evaluated under Social Security Blue Book Listing 14.11.
Depending on the medical evidence, a person may qualify based on:
- certain serious HIV-related diseases
- very low CD4 counts
- qualifying CD4 measurements combined with severe anemia or weight loss
- repeated HIV-related hospitalizations
- repeated manifestations of HIV that result in marked functional limitations
A person who does not meet Listing 14.11 may still qualify through Residual Functional Capacity, or RFC, if HIV and related medical problems prevent sustained work.
Descovy Is Not a Complete HIV Treatment Regimen
This is one of the most important facts about Descovy.
Current NIH guidelines classify Descovy, or TAF/FTC, as a fixed-dose combination of two nucleoside reverse transcriptase inhibitors. The guidelines specifically state that these two-drug NRTI tablets are not complete regimens and must be combined with other antiretroviral medication for HIV treatment.
That means a person taking Descovy for HIV will typically also be taking another antiretroviral medication.
For disability purposes, Social Security should consider the effects of the entire treatment regimen, not Descovy in isolation.
Descovy and Viral Suppression
Descovy may form part of a highly effective HIV regimen.
But an undetectable viral load does not automatically mean someone is capable of full-time work.
A person may continue to have substantial limitations from:
- peripheral neuropathy
- chronic fatigue
- cognitive impairment
- liver disease
- kidney disease
- chronic pain
- residual effects of earlier opportunistic infections
- depression or anxiety
- other medical conditions
The disability analysis should focus on actual functional capacity despite successful antiviral treatment.
Descovy and Fatigue
Fatigue was reported in clinical trials involving Descovy.
In the large DISCOVER PrEP trial, fatigue occurred in approximately 2% of participants receiving Descovy.
Fatigue may also result from:
- HIV itself
- anemia
- chronic infection
- poor sleep
- depression
- chronic pain
- kidney disease
- other medical conditions
Work-related problems may include:
- reduced stamina
- slower pace
- poor concentration
- need for additional breaks
- difficulty working consecutive days
- inability to complete a full shift
Descovy and Diarrhea
Diarrhea is another reported Descovy adverse reaction.
In the DISCOVER PrEP trial, diarrhea was the most common adverse reaction, occurring in approximately 5% of Descovy participants.
Persistent diarrhea may interfere with work through:
- frequent restroom trips
- urgent unscheduled breaks
- inability to remain at a workstation
- dehydration
- weakness
- reduced productivity
- missed work
For a disability claim, frequency and urgency matter.
A person who requires repeated unscheduled restroom breaks may have difficulty maintaining competitive employment even in a sedentary job.
Descovy and Nausea
Nausea has also been reported with Descovy.
In treatment studies involving FTC/TAF as part of an HIV regimen, nausea was the most common adverse reaction at an incidence of at least 10%. In the DISCOVER PrEP trial, nausea occurred in approximately 4% of Descovy participants.
Persistent nausea may contribute to:
- poor appetite
- weakness
- distraction
- reduced concentration
- unscheduled breaks
- missed work
Nausea alone will rarely establish disability, but it may contribute to the overall functional picture.
Descovy and Headaches
Headache was reported in approximately 2% of participants receiving Descovy in the DISCOVER trial.
Frequent headaches may interfere with:
- concentration
- computer use
- reading
- pace
- attendance
- completion of tasks
The disability significance depends on severity, frequency, duration, and treatment response.
Descovy and Kidney Problems
Kidney function is an important consideration with Descovy.
Current prescribing information warns about new onset or worsening renal impairment and recommends monitoring:
- serum creatinine
- estimated creatinine clearance
- urine glucose
- urine protein
In people with chronic kidney disease, serum phosphorus should also be monitored.
Descovy is not recommended in certain patients with severe renal impairment who are not receiving chronic hemodialysis.
Kidney disease may contribute to:
- severe fatigue
- weakness
- swelling
- reduced endurance
- concentration problems
- additional medical treatment
- missed work
Descovy and Bone Health
Tenofovir medications have long been associated with concerns about bone mineral density.
TAF, the form of tenofovir used in Descovy, generally produces lower systemic tenofovir exposure than older tenofovir disoproxil fumarate products, but bone health may still be relevant in some patients.
Clinical-trial data included measurable changes in bone mineral density in people receiving FTC/TAF-containing treatment.
Bone-related limitations may become important when the person also has:
- osteoporosis
- fractures
- chronic musculoskeletal pain
- reduced mobility
- other risk factors for bone loss
The existence of a medication-related risk alone does not establish disability.
Descovy and Hepatitis B
Descovy carries a boxed warning concerning hepatitis B.
Severe acute exacerbations of hepatitis B have been reported after stopping medications containing emtricitabine or tenofovir and may occur when Descovy is discontinued in people with HBV infection.
Current labeling recommends testing for hepatitis B before or when starting Descovy and closely monitoring liver function if Descovy is stopped in someone with HBV.
Hepatitis B complications may cause:
- fatigue
- weakness
- nausea
- liver dysfunction
- reduced stamina
- additional medical treatment
- hospitalization
Descovy and Liver Problems
Current labeling also warns about lactic acidosis and severe hepatomegaly with steatosis, including rare fatal cases associated with nucleoside analog medications.
Possible functional consequences of significant liver disease may include:
- severe fatigue
- weakness
- nausea
- reduced stamina
- difficulty concentrating
- missed work
- hospitalization
A theoretical medication risk does not itself establish disability. Actual liver impairment and functional effects must be documented.
Descovy and Drug Interactions
Descovy can interact with other medications, particularly drugs that affect transport pathways involved in tenofovir alafenamide or medications that affect kidney function.
Current prescribing information recommends reviewing potential drug interactions before and during treatment.
Drug interactions may become relevant to a disability claim when they result in:
- treatment changes
- increased side effects
- additional laboratory monitoring
- reduced medication options
- unstable HIV treatment
The complete medication regimen should always be considered.
Descovy and Peripheral Neuropathy
Descovy is not necessarily the cause of neuropathy in someone living with HIV.
HIV itself and prior treatments may contribute to persistent peripheral neuropathy.
Symptoms may include:
- burning pain
- numbness
- tingling
- weakness
- poor balance
- difficulty walking
- hand dysfunction
Foot neuropathy may interfere with:
- standing
- walking
- climbing
- balance
Hand neuropathy may interfere with:
- typing
- writing
- gripping
- handling
- fingering
Descovy and Cognitive Problems
Some people living with HIV continue to experience neurocognitive symptoms even when HIV is virologically suppressed.
Possible limitations include:
- memory problems
- poor concentration
- slowed thinking
- difficulty organizing tasks
- reduced mental stamina
- difficulty learning new information
At work, these problems may cause:
- mistakes
- forgotten instructions
- missed deadlines
- reduced pace
- excessive off-task time
- difficulty multitasking
Can You Work While Taking Descovy?
Yes.
Many people taking Descovy work without significant restrictions.
Taking HIV medication does not mean a person is disabled.
The more useful questions are:
- Is HIV well controlled?
- What complications remain?
- Is fatigue severe?
- Is neuropathy present?
- Are cognitive problems documented?
- Is kidney or liver disease present?
- Are GI symptoms causing unscheduled breaks?
- Can reliable attendance be maintained?
- Can the person complete a normal workday and workweek?
Two people taking the same medication may have very different functional capacities.
Can Descovy-Related Conditions Prevent Sedentary Work?
Yes.
Sedentary work still requires:
- sustained concentration
- regular attendance
- acceptable pace
- hand use
- limited unscheduled breaks
- some standing and walking
- completion of full workdays
Sedentary work may become unrealistic when:
- severe fatigue limits stamina
- diarrhea requires frequent restroom breaks
- neuropathy affects hand use or walking
- cognitive impairment causes excessive off-task time
- kidney disease reduces endurance
- headaches reduce concentration
- recurrent illness causes excessive absences
Simply being capable of sitting does not establish the ability to sustain competitive employment.
Descovy and Residual Functional Capacity
Residual Functional Capacity, or RFC, describes the most a person can still do despite medically documented limitations.
An HIV claim involving Descovy may include restrictions involving:
- standing
- walking
- lifting
- carrying
- handling
- fingering
- restroom access
- concentration
- pace
- additional breaks
- off-task time
- attendance
For example:
- Fatigue may reduce stamina.
- Diarrhea may require unscheduled restroom breaks.
- Neuropathy may limit mobility or hand use.
- Cognitive symptoms may restrict complex tasks.
- Kidney disease may reduce endurance.
- Recurrent illness may produce excessive absences.
The RFC should reflect the combined effects of HIV, coexisting conditions, and treatment.
Medical Evidence That May Support a Descovy Disability Claim
Helpful evidence may include:
- infectious disease specialist records
- primary care records
- CD4 counts
- viral-load testing
- kidney-function testing
- urinalysis
- serum phosphorus testing when appropriate
- hepatitis B testing
- liver-function testing
- hospitalization records
- infection records
- neuropathy evaluations
- cognitive testing
- psychiatric records
- medication history
- documented side effects
- records of missed work
- provider statements describing functional limitations
The strongest evidence connects medical findings to actual workplace problems.
Documenting Descovy Side Effects
Treatment effects are more persuasive when consistently documented.
Helpful documentation may include:
- diarrhea
- nausea
- fatigue
- headaches
- kidney abnormalities
- liver abnormalities
- medication changes
- treatment interruptions
- clinically significant drug interactions
A disability claim should explain:
- how often symptoms occur
- how long they last
- how severe they are
- how they affect work
Doctor Statements About Work Limitations
A treating provider may be able to address:
- fatigue
- walking tolerance
- neuropathy
- hand use
- restroom needs
- concentration
- cognitive problems
- headaches
- medication effects
- need for additional breaks
- off-task time
- expected absences
- ability to complete a full workday
Specific functional opinions are generally more useful than a broad statement that someone is “disabled.”
Signs Descovy May Be Relevant to Your Disability Claim
Descovy treatment may be relevant when HIV or related medical conditions continue to cause:
- severe fatigue
- recurrent infections
- chronic diarrhea
- neuropathy
- cognitive impairment
- persistent headaches
- kidney dysfunction
- liver disease
- significant treatment complications
- excessive absences
- inability to complete full shifts
When those limitations remain significant despite treatment, the disability claim may be stronger.
Common Mistakes in Descovy Disability Claims
Common problems include:
- relying on the prescription itself as proof of disability
- assuming HIV automatically establishes disability
- assuming viral suppression automatically establishes the ability to work
- failing to document fatigue
- failing to document diarrhea or restroom needs
- overlooking neuropathy
- ignoring cognitive impairment
- failing to document kidney problems
- overlooking liver disease
- failing to explain excessive absences
- failing to connect symptoms to specific RFC limitations
A strong claim focuses on what limitations remain despite successful HIV treatment.
When to Speak With a Social Security Disability Lawyer
Many people seek legal help when:
- their disability claim has been denied
- HIV complications continue despite treatment
- fatigue prevents full-time work
- neuropathy affects mobility or hand use
- diarrhea causes frequent unscheduled breaks
- cognitive problems interfere with employment
- kidney or liver disease creates additional limitations
- recurrent illness causes excessive absences
- Social Security assumes viral suppression means the person can work
Our social security disability attorneys can help evaluate how HIV, Descovy treatment, related medical conditions, and RFC limitations fit into the overall disability claim.
FAQs: Descovy and Social Security Disability Benefits
Can taking Descovy qualify me for Social Security Disability?
Not by itself. Social Security evaluates the underlying HIV infection, medical complications, treatment effects, and ability to sustain full-time work.
What is Descovy?
Descovy contains emtricitabine and tenofovir alafenamide. It is a two-drug NRTI fixed-dose combination used with other antiretroviral medications for HIV treatment.
Is Descovy a complete HIV treatment regimen?
No. For treatment of HIV, Descovy must be combined with other appropriate antiretroviral medications.
Is Descovy also used for PrEP?
Yes. Descovy is FDA-approved for HIV-1 PrEP in certain at-risk adults and adolescents weighing at least 35 kilograms. Its PrEP indication does not include people at risk through receptive vaginal sex because effectiveness in that population has not been established.
What are common Descovy side effects?
In the DISCOVER PrEP trial, diarrhea was the most common adverse reaction, with nausea, headache, fatigue, and abdominal discomfort also reported. In HIV treatment studies involving FTC/TAF-containing regimens, nausea was the most common adverse reaction.
Can Descovy cause kidney problems?
Yes. Current prescribing information warns about new or worsening renal impairment and recommends kidney-function monitoring during treatment.
Why is hepatitis B important when taking Descovy?
Descovy carries a boxed warning because severe acute hepatitis B exacerbations may occur after stopping the medication in people with HBV infection. Hepatitis B testing is recommended before or when starting treatment.
Can Descovy cause fatigue?
Fatigue has been reported in clinical trials. HIV itself and other medical conditions may also cause significant fatigue.
Can I qualify for disability if my viral load is undetectable?
Potentially. Viral suppression does not automatically establish work capacity. Persistent fatigue, neuropathy, cognitive impairment, kidney disease, gastrointestinal symptoms, recurrent illness, or other limitations may still prevent sustained employment.
Can HIV prevent sedentary work?
Yes. Severe fatigue, cognitive impairment, neuropathy, frequent restroom needs, kidney disease, recurrent infections, and excessive absences may make even sedentary work unsustainable.
What should I do if HIV prevents me from working despite treatment with Descovy?
Helpful evidence may include infectious disease records, CD4 and viral-load testing, kidney and liver testing, hepatitis testing, neuropathy evaluations, cognitive records, medication history, documented treatment effects, missed-work records, and provider statements describing specific functional limitations.
What evidence helps prove an amitriptyline-related disability claim?
You may want to speak with a Social Security Disability attorney to evaluate whether your HIV meets Listing 14.11 or whether your combined medical limitations and RFC prevent sustained employment.
Contact MLF Legal for a Free Disability Case Evaluation
If HIV, severe fatigue, neuropathy, cognitive impairment, kidney disease, recurrent infections, Descovy treatment effects, or another medical condition prevents you from working, you may qualify for Social Security Disability benefits.
MLF Legal represents disability applicants nationwide. Based in Dallas, Texas, we help individuals across the country pursue disability benefits.
Our social security lawyers can review your situation for free and explain your options.
📞 Call MLF Legal at 214-357-1782 to request a free consultation.
Next Steps:
1st Sign up For a Free One-on-One Disability Case Evaluation
Contact us today to schedule your personalized one-on-one free phone consultation with one of our dedicated legal professionals. Our experienced social security lawyers are here to provide the expert legal guidance and support you need throughout the entire process of your case.
We understand the complexities involved in social security disability claims and are committed to helping you achieve the best possible outcome. Don’t hesitate to reach out and take the first step toward securing the justice you deserve.
2nd Download Free E-Books
Social Security Disability
Navigating the Social Security Disability Benefits process can be complex, but understanding the key steps can help. From gathering medical records to completing the application, this process ensures eligible individuals receive the support they need. Seeking guidance from experts can simplify the journey and increase the chances of a successful outcome.
Call MLF Legal today
214-357-1782
Fill out our online form
for a free consultation.
We only get paid if we win your case.